Key role for gene dosage and synaptic homeostasis in autism spectrum disorders

Trends in Genetics

Volumn 26, Issue 8, 2010, Pages 363-372

  Toro, Roberto ^a,b   Konyukh, Marina ^a,b   Delorme, Richard ^a,b,c,f   Leblond, Claire ^a,b   Chaste, Pauline ^a,b,c   Fauchereau, Fabien ^a,b,d   Coleman, Mary ^e   Leboyer, Marion ^f,g,j   Gillberg, Christopher ^h,i   Bourgeron, T ^a,b,d,j  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e Foundation for Autism Research   (United States)

^f FONDATION FONDAMENTAL   (France)

^g INSERM   (France)

^h UNIVERSITY OF GOTHENBURG   (Sweden)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j HENRI MONDOR HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUTISM; GENE DOSAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; NERVE CELL NETWORK; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYNAPSE;

ANIMALS; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HOMEOSTASIS; HUMANS; SYNAPSES;

EID: 77955093058     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2010.05.007     Document Type: Review

References (109)

1. Fernell E., Gillberg C. Autism spectrum disorder diagnoses in Stockholm preschoolers. Res. Dev. Disabil. 2010, 31:680-685.
2. Freitag C.M. The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol. Psychiatry 2007, 12:2-22.
3. Abrahams B.S., Geschwind D.H. Advances in autism genetics: on the threshold of a new neurobiology. Nat. Rev. Genet. 2008, 9:341-355.
4. Gillberg C., Coleman M. The Biology of the Autistic Syndromes 2000, Oxford University Press.
5. Szatmari P., et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat. Genet. 2007, 39:319-328.
6. Cook E.H., Scherer S.W. Copy-number variations associated with neuropsychiatric conditions. Nature 2008, 455:919-923.
7. Wang K., et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009, 459:528-533.
8. Weiss L.A., et al. A genome-wide linkage and association scan reveals novel loci for autism. Nature 2009, 461:802-808.
9. Anney, R. et al. (2010) A genomewide scan for common risk variants nominates phospholipase D and polysialyltransferase proteins for a role in autism. (Submitted).
10. Manolio T.A., et al. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
11. Conrad D.F., et al. Origins and functional impact of copy number variation in the human genome. Nature 2010, 464:704-712.
12. Jacquemont M.L., et al. Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. J. Med. Genet. 2006, 43:843-849.
13. Glessner J.T., et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009, 459:569-573.
14. Marshall C.R., et al. Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet. 2008, 82:477-488.
15. Sebat J., et al. Strong association of de novo copy number mutations with autism. Science 2007, 316:445-449.
16. Cho S.C., et al. Copy number variations associated with idiopathic autism identified by whole-genome microarray-based comparative genomic hybridization. Psychiatr. Genet. 2009, 19:177-185.
17. Christian S.L., et al. Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder. Biol. Psychiatry 2008, 63:1111-1117.
18. Bucan M., et al. Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet. 2009, 5:e1000536.
19. Pinto, D. et al. (2010) Functional impact of global rare copy number variation in autism spectrum disorder. Nature (In press) DOI: 10.1038/nature09146.
20. Zweier C., et al. CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. Am. J. Hum. Genet. 2009, 85:655-666.
21. Schanen N.C. Epigenetics of autism spectrum disorders. Hum. Mol. Genet. 2006, 15SpecNo2:R138-150.
22. Serizawa S., et al. One neuron-one receptor rule in the mouse olfactory system. Trends Genet. 2004, 20:648-653.
23. Chess A. Expansion of the allelic exclusion principle?. Science 1998, 279:2067-2068.
24. Esumi S., et al. Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene cluster in single neurons. Nat. Genet. 2005, 37:171-176.
25. Morrow E.M., et al. Identifying autism loci and genes by tracing recent shared ancestry. Science 2008, 321:218-223.
26. Papp B., et al. Dosage sensitivity and the evolution of gene families in yeast. Nature 2003, 424:194-197.
27. Jamain S., et al. Mutations of the X -linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 2003, 34:27-29.
28. Tabuchi K., et al. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007, 318:71-76.
29. Chahrour M., et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008, 320:1224-1229.
30. Ramocki M.B., et al. Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome. Ann. Neurol. 2009, 66:771-782.
31. Kelleher R.J., Bear M.F. The autistic neuron: troubled translation?. Cell 2008, 135:401-406.
32. Tavazoie S.F., et al. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat. Neurosci. 2005, 8:1727-1734.
33. Cook E.H., Leventhal B.L. The serotonin system in autism. Curr. Opin. Pediatr. 1996, 8:348-354.
34. Campbell D.B., et al. A genetic variant that disrupts MET transcription is associated with autism. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:16834-16839.
35. Ehlers M.D. Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat. Neurosci. 2003, 6:231-242.
36. Dindot S.V., et al. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum. Mol. Genet. 2008, 17:111-118.
37. Greer P.L., et al. The Angelman syndrome protein Ube3A regulates synapse development by ubiquitinating Arc. Cell 2010, 140:704-716.
38. Le Meur N., et al. MEF2C haploinsufficiency caused either by microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations. J. Med. Genet. 2009, 47:22-29.
39. Bourgeron T. A synaptic trek to autism. Curr. Opin. Neurobiol. 2009, 19:231-234.
40. Sudhof T.C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008, 455:903-911.
41. Chih B., et al. Disorder-associated mutations lead to functional inactivation of neuroligins. Hum. Mol. Genet. 2004, 13:1471-1477.
42. Zhang C., et al. A neuroligin-4 missense mutation associated with autism impairs neuroligin-4 folding and endoplasmic reticulum export. J. Neurosci. 2009, 29:10843-10854.
43. Laumonnier F., et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am. J. Hum. Genet. 2004, 74:552-557.
44. Jamain S., et al. Mutations of the X- linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 2003, 34:27-29.
45. Lawson-Yuen A., et al. Familial deletion within NLGN4 associated with autism and Tourette syndrome. Eur. J. Hum. Genet. 2008, 16:614-618.
46. Macarov M., et al. Deletions of VCX-A and NLGN4: a variable phenotype including normal intellect. J. Intellect. Disabil. Res. 2007, 51:329-333.
47. Chadman K.K., et al. Minimal aberrant behavioural phenotypes of neuroligin-3 R451C knockin mice. Autism Res. 2008, 1:147-158.
48. Jamain S., et al. Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:1710-1715.
49. Dahlhaus R., El-Husseini A. Altered neuroligin expression is involved in social deficits in a mouse model of the fragile X Syndrome. Behav. Brain Res. 2009, 208:96-105.
50. Biswas S., et al. Sensory regulation of neuroligins and neurexin I in the honeybee brain. PLoS One 2010, 5:e9133.
51. Durand C.M., et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 2007, 39:25-27.
52. Moessner R., et al. Contribution of SHANK3 mutations to autism spectrum disorder. Am. J. Hum. Genet. 2007, 81:1289-1297.
53. Gauthier J., et al. Novel de novo SHANK3 mutation in autistic patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 150B:421-424.
54. Roussignol G., et al. Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons. J. Neurosci. 2005, 25:3560-3570.
55. Persico A.M., Bourgeron T. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci. 2006, 29:349-358.
56. Sutcliffe J.S., et al. Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am. J. Hum. Genet. 2005, 77:265-279.
57. Jamain S., et al. Linkage and association of the glutamate receptor 6 gene with autism. Mol. Psychiatry 2002, 7:302-310.
58. Delahanty, R.J. et al. (2009) Maternal transmission of a rare GABRB3 signal peptide variant is associated with autism. Mol. Psychiatry (In press) DOI: 10.1038/mp.2009.118.
59. Melin M., et al. Constitutional downregulation of SEMA5A expression in autism. Neuropsychobiology 2006, 54:64-69.
60. Alarcon M., et al. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am. J. Hum. Genet. 2008, 82:150-159.
61. Arking D.E., et al. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am. J. Hum. Genet. 2008, 82:160-164.
62. Bakkaloglu B., et al. Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am. J. Hum. Genet. 2008, 82:165-173.
63. Roohi J., et al. Disruption of contactin 4 in three subjects with autism spectrum disorder. J. Med. Genet. 2009, 46:176-182.
64. Turrigiano G.G. Homeostatic plasticity in neuronal networks: the more things change, the more they stay the same. Trends Neurosci. 1999, 22:221-227.
65. Tononi G., Cirelli C. Sleep and synaptic homeostasis: a hypothesis. Brain Res. Bull. 2003, 62:143-150.
66. Macleod G.T., Zinsmaier K.E. Synaptic homeostasis on the fast track. Neuron 2006, 52:569-571.
67. Turrigiano G.G., Nelson S.B. Homeostatic plasticity in the developing nervous system. Nat. Rev. Neurosci. 2004, 5:97-107.
68. Ramocki M.B., Zoghbi H.Y. Failure of neuronal homeostasis results in common neuropsychiatric phenotypes. Nature 2008, 455:912-918.
69. Yu L.M., Goda Y. Dendritic signalling and homeostatic adaptation. Curr. Opin. Neurobiol. 2009, 19:327-335.
70. Bourgeron T. The possible interplay of synaptic and clock genes in autism spectrum disorders. Cold Spring Harb. Symp. Quant. Biol. 2007, 72:645-654.
71. Melke J., et al. Abnormal melatonin synthesis in autism spectrum disorders. Mol. Psychiatry 2008, 13:90-98.
72. Miller G. Neuroscience. Sleeping to reset overstimulated synapses. Science 2009, 324:22.
73. Stickgold R., Walker M.P. Memory consolidation and reconsolidation: what is the role of sleep?. Trends Neurosci. 2005, 28:408-415.
74. Somerville M.J., et al. Severe expressive-language delay related to duplication of the Williams-Beuren locus. N. Engl. J. Med. 2005, 353:1694-1701.
75. Weiss L.A., et al. Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 2008, 358:667-675.
76. Kumar R.A., et al. Recurrent 16p11.2 microdeletions in autism. Hum. Mol. Genet. 2008, 17:628-638.
77. McCarthy S.E., et al. Microduplications of 16p11.2 are associated with schizophrenia. Nat. Genet. 2009, 41:1223-1227.
78. Elsea S.H., Girirajan S. Smith-Magenis syndrome. Eur. J. Hum. Genet. 2008, 16:412-421.
79. Potocki L., et al. Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype. Am. J. Hum. Genet. 2007, 80:633-649.
80. Niklasson L., et al. Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome. Res. Dev. Disabil. 2009, 30:763-773.
81. Cai G., et al. Multiplex ligation-dependent probe amplification for genetic screening in autism spectrum disorders: efficient identification of known microduplications and identification of a novel microduplication in ASMT. BMC Med. Genomics 2008, 1:50.
82. Gauthier, J. et al. (2010) De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 107, 7863-7868.
83. Garber K.B., et al. Fragile X syndrome. Eur. J. Hum. Genet. 2008, 16:666-672.
84. Amir R.E., et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 1999, 23:185-188.
85. Wiznitzer M. Autism and tuberous sclerosis. J. Child. Neurol. 2004, 19:675-679.
86. Rosser T.L., Packer R.J. Neurocognitive dysfunction in children with neurofibromatosis type 1. Curr. Neurol. Neurosci. Rep. 2003, 3:129-136.
87. Butler M.G., et al. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J. Med. Genet. 2005, 42:318-321.
88. Splawski I., et al. CACNA1H mutations in autism spectrum disorders. J. Biol. Chem. 2006, 281:22085-22091.
89. Feng J., et al. High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neurosci. Lett. 2006, 409:10-13.
90. Fernandez T., et al. Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome. Am. J. Hum. Genet. 2008, 82:1385.
91. Verkerk A.J., et al. CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. Genomics 2003, 82:1-9.
92. Friedman J.I., et al. CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol. Psychiatry 2008, 13:261-266.
93. Castermans D., et al. The neurobeachin gene is disrupted by a translocation in a patient with idiopathic autism. J. Med. Genet. 2003, 40:352-356.
94. Gauthier J., et al. Novel de novo SHANK3 mutation in autistic patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 150B:421-424.
95. Jamain S., et al. Mutations of the X - linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 2003, 34:27-29.
96. Piton A., et al. Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Hum. Mol. Genet. 2008, 17:3965-3974.
97. Melke J., et al. Abnormal melatonin synthesis in autism spectrum disorders. Mol. Psychiatry 2008, 13:90-98.
98. Toma C., et al. Is ASMT a susceptibility gene for autism spectrum disorders? A replication study in European populations. Mol. Psychiatry 2007, 12:977-979.
99. Williams J.M., et al. A 1q42 deletion involving DISC1, DISC2, and TSNAX in an autism spectrum disorder. Am. J. Med. Genet. A 2009, 149A:1758-1762.
100. Petek E., et al. Molecular and genomic studies of IMMP2L and mutation screening in autism and Tourette syndrome. Mol. Genet. Genomics 2007, 277:71-81.
101. Turunen J.A., et al. Mitochondrial aspartate/glutamate carrier SLC25A12 gene is associated with autism. Autism Res. 2008, 1:189-192.
102. Ramoz N., et al. Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism. Am. J. Psychiatry 2004, 161:662-669.
103. Skaar D.A., et al. Analysis of the RELN gene as a genetic risk factor for autism. Mol. Psychiatry 2005, 10:563-571.
104. Bonora E., et al. Mutation screening and association analysis of six candidate genes for autism on chromosome 7q. Eur. J. Hum. Genet. 2005, 13:198-207.
105. Benayed R., et al. Support for the homeobox transcription factor gene ENGRAILED 2 as an autism spectrum disorder susceptibility locus. Am. J. Hum. Genet. 2005, 77:851-868.
106. Barnby G., et al. Candidate-gene screening and association analysis at the autism-susceptibility locus on chromosome 16p: evidence of association at GRIN2A and ABAT. Am. J. Hum. Genet. 2005, 76:950-966.
107. Devlin B., et al. Autism and the serotonin transporter: the long and short of it. Mol. Psychiatry 2005, 10:1110-1116.
108. Weiss L.A., et al. Variation in ITGB3 is associated with whole-blood serotonin level and autism susceptibility. Eur. J. Hum. Genet. 2006, 14:923-931.
109. Kilpinen H., et al. Linkage and linkage disequilibrium scan for autism loci in an extended pedigree from Finland. Hum. Mol. Genet. 2009, 18:2912-2921.